Blue Note Therapeutics | Helping Patients Live Better
Summary
“Nearly half of all patients diagnosed with cancer experience some form of psychosocial distress but for far too many these symptoms go untreated,” said Geoffrey Eich, CEO of Blue Note Therapeutics. We aim to make treatment accessible to any cancer patient, at any time, by merging deep scientific and clinical expertise, neuroscience, and digital innovation. Working closely with cancer research and patient communities, we are developing a pipeline of clinically validated prescription digital therapeutics to help reduce anxiety, depression, and other forms of cancer-related distress. JAZZ Venture Partners invests in companies that extend the boundaries of human performance - improving how we live, learn, work, play, and experience the world. JAZZ portfolio companies are unlocking human potential in health, mind-body wellness, accelerated learning and training, sports, entertainment, and the enterprise.